DIVERSA Technologies
Abi J Vázquez is a highly experienced professional with a diverse background in biology and molecular medicine. Currently serving as Cofounder and Chief Operating Officer at DIVERSA since June 2021, Abi is responsible for planning, executing, and overseeing strategic directives and daily operations across various areas, including sales and marketing. Prior to this role, Abi was involved in significant research positions, including postdoctoral researcher at Instituto de Investigación Sanitaria de Santiago de Compostela and doctoral studies at Universidade de Santiago de Compostela, culminating in a PhD in molecular medicine. Additional experience includes collaborations at IRCCS Istituto Nazionale dei Tumori in Italy and multiple research projects focused on novel therapeutic strategies. Abi's educational foundation includes degrees in biology and biomedical research from universities in Spain.
This person is not in any teams
DIVERSA Technologies
Our drug delivery technology based on lipidic nanoemulsions allows for safe and physiological intracellular delivery of complex macromolecules (peptides, proteins and nucleic acids) and small hydrophobic molecules. The platform has broad and fresh IP protection and is fully scalable and regulatory compliant. At DIVERSA, we want to bridge the gap between molecules and patients, between drug discovery and clinical application. We want to create new opportunities to improve patients' quality of life. Despite the discovery of many new targets and therapeutic molecules in labs around the world, less than 3% of them will make it to clinical stages. Most of these new molecules are discarded in the early stages of research, mostly because they cannot access the interior of the cell, where 3 out of 4 new molecules have their targets. We want change that. We want to spearhead the therapeutic revolution.